Does APIXABAN Cause Anosmia? 374 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 374 reports of Anosmia have been filed in association with APIXABAN (ELIQUIS). This represents 0.2% of all adverse event reports for APIXABAN.
374
Reports of Anosmia with APIXABAN
0.2%
of all APIXABAN reports
0
Deaths
106
Hospitalizations
How Dangerous Is Anosmia From APIXABAN?
Of the 374 reports, 106 (28.3%) required hospitalization, and 99 (26.5%) were considered life-threatening.
Is Anosmia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 374 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Anosmia?
DUPILUMAB (976)
FLUTICASONE (490)
LEVOTHYROXINE (380)
CETIRIZINE (376)
NAPROXEN (370)
LANSOPRAZOLE (360)
ESOMEPRAZOLE (351)
SIMVASTATIN (349)
DIGOXIN (348)
ISOSORBIDE MONONITRATE (346)
Which APIXABAN Alternatives Have Lower Anosmia Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ